Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1976-1-23
pubmed:abstractText
Using a randomized crossover design involving 12 normal subjects, we studied comparatively the pharmacokinetics and tolerance of three aminoglycoside antibiotics, gentamicin, sisomicin, and tobramycin. Serum concentrations were determined during 8 h and the urine recovery rate was determined within 24 h after a 1-h intravenous infusion of the respective antibiotic in a dose of 1 mg/kg of body weight. Microbiological assay was performed with the agar diffusion test (Bacillus subtilis); pharmacokinetic calculations were performed by means of a digital computer on the basis of a mathematical model of an open, two-compartment system. Of the three antibiotics studied, gentamicin showed the lowest concentration in serum after termination of the 1-h infusion (3.85 +/- 0.67 mug/ml), and the serum-regression curve steadily lay below those of the two other antibiotics. Sisomicin had the highest serum concentrations (4,66 +/- 1.24 mug/ml) and the serum-level curve exceeded that of the two other antibiotics. Tobramycin occupied a position between sisomicin and gentamicin in form of its serum level characteristics. Corresponding to the serum kinetics we also found slight differences in the pharmacokinetic parameters, especially in serum half-lives, elimination constants, and areas under the serum level curves. The test of liver and kidney functions and the hematological systems, as well as the function of the stato-acusticus nerve, showed no pathological changes by any of the three antibiotics tested.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-14172278, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4131032, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4208289, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4208290, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4670427, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4670437, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4698568, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4790551, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4790560, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4790568, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4790572, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4790579, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4793881, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4842335, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4974678, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-4992170, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-5067482, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-5126254, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-5411325, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-5487129, http://linkedlifedata.com/resource/pubmed/commentcorrection/1103722-5487130
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
396-401
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1975
pubmed:articleTitle
[Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin].
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Controlled Clinical Trial